ArticleCancers2024

Patient-Specific Circulating Tumor DNA for Monitoring Response to Menin Inhibitor Treatment in Preclinical Models of Infant Leukemia.

Louise Doculara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.